Diabetes Mellitus, Non-Insulin-Dependent
66
0
0
60
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
16 trials with published results (24%)
Research Maturity
60 completed trials (91% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
1.5%
1 terminated out of 66 trials
98.4%
+11.9% vs benchmark
38%
25 trials in Phase 3/4
27%
16 of 60 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 60 completed trials
Clinical Trials (66)
Technology Intensified Diabetes Education Study in African Americans
Evaluation of Advanced Glycation End-products (AGE) and the Erectile Dysfunction (DE) in Diabetic Patients
Telephone Delivered Behavioral Skills Intervention for Blacks With T2DM
The Effects of Nutritional Intervention on Health Parameters in Participants With Type 2 Diabetes Mellitus
Translating Healthy Lifestyle Interventions for Cancer Survivors
PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA
Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes
To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study
Saxagliptin and Cardiac Structure and Function
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events
A Pilot Study on Effect of SKY on Psychosocial Parameters of Type 2 Diabetic Patients After a 6 Days
Diabetes Prevention Program
A Lifestyle Intervention for Type 2 Diabetes Patients in Kuwait and Its Impact on Glycaemic Control
Effect of Gelofusine on GLP1-receptor Imaging
Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)
The Effect of Sitagliptin in Type 2 Diabetes Mellitus With Inadequate Glycemic Control (MK0431-118)
MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)
Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)
Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills
Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)